ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 610173 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 610173; 2) Community: the network communities that were significantly associated with the response to NSC 610173; 3) Molecule: the relationships between components within communities and NSC 610173; 4) MDR: the compounds that were significantly associated with the NSC 610173.

NSC Compound Enrichment Correlation
NSC 671314 Null 0.00862782236704185 -0.19048004
NSC 680219 Null 0.00862782236704185 -0.2538053
NSC 692576 3-Pyridinecarboxylic acid, 2-[[(2-chloro-3-pyridinyl)amino]carbonyl]-1,4-dihydro- 4-(2,4-dimethoxyphenyl)-1-(4-methoxy-2-nitrophenyl)- 6-(4-methylphenyl)-, methyl ester 0.00862782236704185 -0.24143972
NSC 699071 Null 0.00862782236704185 -0.14946596
NSC 701574 Androst-4-en-3-one, 17-ethynyl-17-hydroxy-, 3-O-[2-(1-pyrrolidinyl)ethyl]oxime, (17.beta.)- 0.00862782236704185 -0.21395119
NSC 707054 Null 0.00862782236704185 -0.18152847
NSC 709435 Null 0.00862782236704185 -0.043929128
NSC 719376 Null 0.00862782236704185 -0.26374252
NSC 725047 5,6-Dihydro-5,11-dioxo-5-(propyl-3'-t-butoxycarbamoyl)-11H-i ndeno[1,2-c]isoquinoline 0.00862782236704185 0.52130781
NSC 727082 16-[3-Methoxy-4-(2-piperidin-1-yl ethoxy)benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.00862782236704185 -0.19076283
Total:111  Current:25    [First] [Prev] [Next] [Last]